Blood Res.  2017 Sep;52(3):219-221. 10.5045/br.2017.52.3.219.

A case of synchronous multiple myeloma and chronic myeloid leukemia

  • 1Department of Internal Medicine, Hemato-Oncology, Inje University College of Medicine, Busan Paik Hospital, Busan, Korea.
  • 2Department of Pathology, Inje University College of Medicine, Busan Paik Hospital, Busan, Korea.


No abstract available.

MeSH Terms

Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
Multiple Myeloma*


  • Fig. 1 Biopsy of the right pleural soft-tissue mass. (A) Infiltration of plasma cells (H&E staining, ×400). (B) Positive for immunohistochemical staining of CD138 (×100).

  • Fig. 2 Bone marrow biopsy and aspiration at diagnosis. (A) Bone marrow biopsy shows increased cellularity up to 90% (H&E, ×100). (B) Bone marrow aspiration shows myeloid hyperplasia with increased eosinophils (Wright-Giemsa staining, ×1,000). (C) Bone marrow aspiration shows increased mature forms of plasma cells (Wright-Giemsa staining, ×1,000).

Cited by  1 articles

Emergence of chronic myeloid leukemia following autologous stem cell transplantation in a young woman with multiple myeloma
Aisling Barrett, Siobhán Glavey, Jeremy Sargent, Patrick Thornton, Philip Murphy, John Quinn
Blood Res. 2018;53(3):254-256.    doi: 10.5045/br.2018.53.3.254.


1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65:5–29. PMID: 25559415.
2. Hong J, Lee JH. Recent advances in multiple myeloma: a Korean perspective. Korean J Intern Med. 2016; 31:820–834. PMID: 27604794.
3. Au WY, Caguioa PB, Chuah C, et al. Chronic myeloid leukemia in Asia. Int J Hematol. 2009; 89:14–23. PMID: 19101781.
4. Greipp PR, San Miguel J, Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol. 2005; 23:3412–3420. PMID: 15809451.
5. Sokal JE, Cox EB, Baccarani M, et al. Prognostic discrimination in “good-risk” chronic granulocytic leukemia. Blood. 1984; 63:789–799. PMID: 6584184.
6. Ide M, Kuwahara N, Matsuishi E, Kimura S, Gondo H. Uncommon case of chronic myeloid leukemia with multiple myeloma. Int J Hematol. 2010; 91:699–704. PMID: 20352382.
7. Alsidawi S, Ghose A, Qualtieri J, Radhakrishnan N. A case of multiple myeloma with metachronous chronic myeloid leukemia treated successfully with bortezomib, dexamethasone, and dasatinib. Case Rep Oncol Med. 2014; 2014:962526. PMID: 25544920.
8. Offiah C, Quinn JP, Thornton P, Murphy PT. Co-existing chronic myeloid leukaemia and multiple myeloma: rapid response to lenalidomide during imatinib treatment. Int J Hematol. 2012; 95:451–452. PMID: 22426625.
9. Monroy RH, Vargas-Viveros P, Ceballos EC, Velazquez JC, Munos SC. Imatinib (IM) plus thalidomide (Thali), a effective combination for the treatment of chronic myeloid leukemia (CML) Philadelphia chromosomepositive (Ph +) in IM-resistant disease. Report of 14 new cases from a single center in Mexico. Blood. 2013; 122:5172.
Full Text Links
  • BR
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: